✦ LIBER ✦

Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy

✍ Scribed by Bousquet, Corinne; Lasfargues, Charline; Chalabi, Mounira; Billah, Siham Moatassim; Susini, Christiane; Vezzosi, Delphine; Caron, Philippe; Pyronnet, Stéphane

Book ID: 118251110
Publisher: Endocrine Society
Year: 2012
Tongue: English
Weight: 155 KB
Volume: 97
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2011-2088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Compensatory activation of Akt in respon

Compensatory activation of Akt in response to mTOR and Raf inhibitors – A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease

✍ Kathrin Zitzmann; Janina von Rüden; Stephan Brand; Burkhard Göke; Jennifer Licht 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Tumor interaction with hemostasis: The r

Tumor interaction with hemostasis: The rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer

✍ Hamid Al-Mondhiry 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

Optimizing the use of aromatase inhibito

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

✍ Walter Jonat; Felix Hilpert 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 412 KB